Generic Drug Price Reduction: How Much Benefit Will It Bring to Patients?
These days, the pharmaceutical industry is focused on the topic of 'drug price reduction.' As the government announced its intention to lower the...
Search results for "pharmaceutical industry"
Pharmaceutical Industry Establishes Successive R&BD Subsidiaries... Is Yuhan Corporation Joining?
Yuhan Corporation recently announced plans to establish a specialized subsidiary for 'Research and Business Development (R&BD)' called 'New Co' to...
Rznomics to Present Oral Report on Breakthrough Anti-Cancer Gene Therapy at AACR
Rznomics, a biotechnology company specializing in RNA-based gene therapies, announced on March 5 that it has been...
Alteogen Poised for Surge in Milestone Revenue as Keytruda Qlex and Biosimilars Gain Momentum
Alteogen is set to accelerate its financial growth this year, driven by a surge in milestone payments and royalty...
VigenCell "Primary Endpoint Achieved"... Will a Domestic NK/T Lymphoma New Drug Be Born?
VigenCell has announced plans to apply for conditional approval within the year as it successfully completed...
U.S. and EU Escalate Pressure on China: A Turning Point for K-Bio?
As the United States prepares to announce the initial regulatory targets of the Biosecurity Act this week, market...
K-Bio Targets Global Expansion: HK inno.N and HLB Seek FDA Approval
South Korean pharmaceutical and biotech companies are aggressively pursuing product approvals and clinical trials with...
Launch of 'TrumpRX' Sells Drugs at Steep Discounts: Will Celltrion and Samsung Biologics Face Price Pressure?
The prescription drug sales platform 'TrumpRX', named after U. S. President Donald Trump, has officially launched.
Dementia Injection Drug ‘Lecanemab’ Formulation and Dosage Diversification... Will It Compete with Oral Medications?
American Biogen and Japanese Eisai are moving quickly to change the formulation and dosage of the dementia treatment...
NVIDIA and Eli Lilly Establish 'AI Drug Research Institute' with Up to $1.4 Trillion Investment Over 5 Years
Semiconductor company NVIDIA is partnering with global pharmaceutical company Eli Lilly to establish an artificial...
powered by 